165 related articles for article (PubMed ID: 11425408)
1. Crohn's disease: genetic susceptibility, bacteria, and innate immunity.
Van Heel DA; McGovern DP; Jewell DP
Lancet; 2001 Jun; 357(9272):1902-4. PubMed ID: 11425408
[No Abstract] [Full Text] [Related]
2. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH
Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577
[TBL] [Abstract][Full Text] [Related]
3. [NOD2 gene mutation associated with susceptibility to Crohn's disease. Evidence of an alteration with links genetic and environmental factors].
Gutiérrez-Ruiz MC; Robles-Díaz G
Rev Invest Clin; 2001; 53(5):386-7. PubMed ID: 11795102
[No Abstract] [Full Text] [Related]
4. Genetic susceptibility and regulation of inflammation in Crohn's disease. Relationship with the innate immune system.
Peña AS; Peñate M
Rev Esp Enferm Dig; 2002 Jun; 94(6):351-60. PubMed ID: 12432592
[No Abstract] [Full Text] [Related]
5. Crohn's gene identified.
Frankish H
Lancet; 2001 May; 357(9269):1678. PubMed ID: 11425381
[No Abstract] [Full Text] [Related]
6. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.
Elson CO
N Engl J Med; 2002 Feb; 346(8):614-6. PubMed ID: 11856802
[No Abstract] [Full Text] [Related]
7. Identification of a Crohn's disease susceptibility gene.
Slow E
Clin Genet; 2001 Sep; 60(3):174-6. PubMed ID: 11595017
[No Abstract] [Full Text] [Related]
8. The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis.
D'Amato M; Sorrentino R; Pettersson S
J Rheumatol; 2002 Nov; 29(11):2470-1. PubMed ID: 12415614
[No Abstract] [Full Text] [Related]
9. [From gene to disease; 'frame shift'-mutation in the CARD15-gene and Crohn's disease].
van der Linde K; Kuipers EJ; de Rooij FW; Wilson JH
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2539-42. PubMed ID: 12532667
[TBL] [Abstract][Full Text] [Related]
10. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
Press RD
Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
[No Abstract] [Full Text] [Related]
11. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
Hampe J; Cuthbert A; Croucher PJ; Mirza MM; Mascheretti S; Fisher S; Frenzel H; King K; Hasselmeyer A; MacPherson AJ; Bridger S; van Deventer S; Forbes A; Nikolaus S; Lennard-Jones JE; Foelsch UR; Krawczak M; Lewis C; Schreiber S; Mathew CG
Lancet; 2001 Jun; 357(9272):1925-8. PubMed ID: 11425413
[TBL] [Abstract][Full Text] [Related]
12. NOD2 (CARD15), the first susceptibility gene for Crohn's disease.
McGovern DP; van Heel DA; Ahmad T; Jewell DP
Gut; 2001 Dec; 49(6):752-4. PubMed ID: 11709505
[No Abstract] [Full Text] [Related]
13. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Philpott DJ; Viala J
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.
Newman B; Siminovitch K
Clin Invest Med; 2003 Dec; 26(6):303-14. PubMed ID: 14690304
[TBL] [Abstract][Full Text] [Related]
15. New targets for Crohn's disease.
Pestell K
Trends Pharmacol Sci; 2001 Jul; 22(7):342. PubMed ID: 11431024
[No Abstract] [Full Text] [Related]
16. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
Hugot JP; Chamaillard M; Zouali H; Lesage S; Cézard JP; Belaiche J; Almer S; Tysk C; O'Morain CA; Gassull M; Binder V; Finkel Y; Cortot A; Modigliani R; Laurent-Puig P; Gower-Rousseau C; Macry J; Colombel JF; Sahbatou M; Thomas G
Nature; 2001 May; 411(6837):599-603. PubMed ID: 11385576
[TBL] [Abstract][Full Text] [Related]
17. Bowel disease gets the Nod.
Weitzman JB
Trends Mol Med; 2001 Aug; 7(8):335-6. PubMed ID: 11516975
[No Abstract] [Full Text] [Related]
18. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
[TBL] [Abstract][Full Text] [Related]
20. Crohn's associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis.
Sawcer S; Maranian M; Hensiek A; Roxburgh R; Gray J; Compston A
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1157. PubMed ID: 12876263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
